Patents by Inventor Qingqin S. Li

Qingqin S. Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of depression
    Patent number: 10098854
    Abstract: The present invention is directed to method for the treatment of depression, for example, treatment resistant depression; wherein the treatment regimen is adjusted depending on the patient's genotype at SNP rs4306882.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: October 16, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Wayne C. Drevets, Qingqin S. Li
  • METHOD FOR THE TREATMENT OF DEPRESSION
    Publication number: 20160045455
    Abstract: The present invention is directed to method for the treatment of depression, for example, treatment resistant depression; wherein the treatment regimen is adjusted depending on the patient's genotype at SNP rs4306882.
    Type: Application
    Filed: August 12, 2015
    Publication date: February 18, 2016
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Wayne C. Drevets, Qingqin S. Li
  • METHODS OF TREATING PSYCHOSIS AND SCHIZOPHRENIA BASED ON POLYMORPHISMS IN THE ERBB4 GENE
    Publication number: 20100144781
    Abstract: The present application is directed to the use of genetic polymorphism in the ErbB4 gene to predict whether a patient is likely to respond to psychotic medication Paliperidone. The polymorphism in the ErbB4 gene is also used to predict whether a patient is likely to display placebo effect among patients in need of psychotic treatment. A method of treating patients with antipsychotic medication Paliperidone using the polymorphism in the ErbB4 gene and a kit of are also provided.
    Type: Application
    Filed: October 29, 2009
    Publication date: June 10, 2010
    Inventors: Dong-Jing Fu, Qingqin S. Li, Dai Wang